ARTICLE
|
doi:10.20944/preprints202110.0121.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
botulinum toxin; subtype A2; clinical tolerability; safety
Online: 7 October 2021 (15:02:29 CEST)